Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-21

FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA has approved Cosette Pharmaceuticals' supplemental application for Welchol (colesevelam hydrochloride). This action constitutes an approved modification…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Welchol (colesevelam hydrochloride)

Snippet

SUPPL AP for WELCHOL (COLESEVELAM HYDROCHLORIDE)